Kangmei Pharmaceutical Co Ltd (600518) — Cash Flow Reinvestment Rate
Kangmei Pharmaceutical Co Ltd (600518) has a Cash Flow Reinvestment Rate of 0.22x as of September 2025, reinvesting CN¥48.57 Million (capex CN¥48.57 Million ) from operating cash flow of CN¥219.96 Million. See Kangmei Pharmaceutical Co Ltd (600518) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kangmei Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2021)
Historical reinvestment intensity for Kangmei Pharmaceutical Co Ltd across 22 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Kangmei Pharmaceutical Co Ltd.
Annual Cash Flow Reinvestment Rate for Kangmei Pharmaceutical Co Ltd (1999–2021)
Year-by-year capital reinvestment analysis for Kangmei Pharmaceutical Co Ltd. See how financially flexible is Kangmei Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.80x | CN¥171.64 Million | CN¥214.21 Million | CN¥171.63 Million | ▲ +173.9% |
| 2020 | 0.29x | CN¥301.74 Million | CN¥1.03 Billion | CN¥301.73 Million | ▲ +7.2% |
| 2019 | 0.27x | CN¥786.25 Million | CN¥2.88 Billion | CN¥473.20 Million | ▼ -98.2% |
| 2018 | 15.06x | CN¥4.60 Billion | CN¥305.62 Million | CN¥4.59 Billion | ▲ +1429.0% |
| 2016 | 0.99x | CN¥1.58 Billion | CN¥1.60 Billion | CN¥1.57 Billion | ▼ -63.8% |
| 2015 | 2.73x | CN¥1.39 Billion | CN¥508.86 Million | CN¥1.37 Billion | ▲ +352.4% |
| 2014 | 0.60x | CN¥682.06 Million | CN¥1.13 Billion | CN¥682.06 Million | ▲ +43.4% |
| 2013 | 0.42x | CN¥703.43 Million | CN¥1.67 Billion | CN¥703.43 Million | ▼ -69.8% |
| 2012 | 1.39x | CN¥1.41 Billion | CN¥1.01 Billion | CN¥1.41 Billion | ▼ -65.5% |
| 2011 | 4.04x | CN¥2.32 Billion | CN¥574.96 Million | CN¥2.32 Billion | ▲ +251.7% |
| 2010 | 1.15x | CN¥768.02 Million | CN¥669.19 Million | CN¥768.02 Million | ▼ -81.1% |
| 2009 | 6.06x | CN¥724.25 Million | CN¥119.47 Million | CN¥724.25 Million | ▼ -97.4% |
| 2008 | 229.90x | CN¥693.14 Million | CN¥3.02 Million | CN¥693.14 Million | ▲ +11285.6% |
| 2007 | 2.02x | CN¥328.23 Million | CN¥162.55 Million | CN¥328.23 Million | ▼ -66.6% |
| 2006 | 6.05x | CN¥413.45 Million | CN¥68.32 Million | CN¥413.45 Million | ▲ +3496.3% |
| 2005 | 0.17x | CN¥22.40 Million | CN¥133.13 Million | CN¥22.40 Million | ▼ -91.2% |
| 2004 | 1.91x | CN¥150.20 Million | CN¥78.52 Million | CN¥150.20 Million | ▲ +206.9% |
| 2003 | 0.62x | CN¥48.63 Million | CN¥78.02 Million | CN¥48.63 Million | ▼ -83.5% |
| 2002 | 3.79x | CN¥202.41 Million | CN¥53.47 Million | CN¥202.41 Million | ▼ -49.0% |
| 2001 | 7.43x | CN¥116.54 Million | CN¥15.69 Million | CN¥116.54 Million | ▲ +4442.5% |
| 2000 | 0.16x | CN¥1.63 Million | CN¥9.96 Million | CN¥1.63 Million | ▼ -61.8% |
| 1999 | 0.43x | CN¥12.96 Million | CN¥30.25 Million | CN¥12.96 Million | — |